Tumor Necrosis Factor Alpha News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tumor necrosis factor alpha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tumor Necrosis Factor Alpha Today - Breaking & Trending Today

SciRhom Files Clinical Trial Application for First-in-Human Trials of Novel Antibody Against Autoimm

MUNICH, Germany, November 15, 2023 / B3C newswire / SciRhom GmbH, a pioneering biotech enterprise specialized in developing first-in-class therapeutic antibodies, announced today the achievement of a significant milestone in its development pipeline. The company has submitted a Clinical Trial Application for its. ....

Jan Poth , Jens Ruhe , Scirhom Gmb , Scirhom Gmbh , Clinical Trial Application , Managing Director , Wuxi Biologics , Rhom Gmbh , Special Surgery , High Tech Gruenderfonds , Autoimmune Diseases , Tumor Necrosis Factor Alpha , Intracellular Signaling Peptides , Signal Transduction , Erbb Receptors , Lupus Nephritis , Inflammatory Bowel Diseases , Pharmaceutical Preparations , Biological Products ,

Charting the future of IBD treatment: From immune modulators to microRNA therapies

In a recent study published in the journal eGastroenterology, researchers delved into the latest therapeutic strategies for managing inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease. The paper discusses emerging treatments ranging from immune-modulating drugs and biologics to novel approaches like microRNA upregulators and stem cell therapies, highlighting the need for precision medicine in IBD care. ....

United States , United Kingdom , Jo Panuwatd Shutterstock , Inflammatory Bowel Disease , Immune Response , De Inhibitors , Small Molecules , Tumor Necrosis Factor , Tumor Necrosis Factor Alpha , Ulcerative Colitis ,